PeptEye independently reconstructs and documents the evidence behind your peptide supply chain — molecule by molecule, supplier by supplier.
Supplier Evidence Audit — from $2,500
You make a go/no-go sourcing call on every reorder. Right now, you make it blindly.
PeptEye can reconstruct a clinic's advertised peptide estate from public information before ever speaking to the practice. The question is whether the supply chain behind it is equally well documented.
A peptide estate does not resolve to a single answer, and we do not give it one.
What are you actually offering?
What sourcing and provenance claims are attached to that estate?
What can independently be established about suppliers, pharmacies, laboratories, certificates, registrations and the published federal record?
What can only your records establish?
You receive a dated Supplier Evidence Register covering the entire agreed estate — not a pass/fail score, and not a generic compliance checklist.
Six pages. A complete public-source reconstruction of one clinic's peptide supply chain — the estate, the sourcing claims, what could be independently established, and the questions only that clinic's own records can close.
View Sample Supplier Evidence Register →
Every compound and every supplier in the agreed estate, with each finding dated to the day it was established.
The underlying records as retrieved, retained so the file can be produced later — including after a supplier's own materials change or disappear.
An explicit list of what the public record cannot close, and what your internal records would need to answer.
"We could not find it" and "it does not exist" are different findings. We keep them separate.
Independently established from a primary source, and dated to the day it was established.
Never means the product is sound. It means the record exists.
We reached the stated sources, worked them through, and the evidence was not there.
Never means it does not exist — only that it is not published.
A source exists but could not be reached, or sits outside the agreed scope.
Never reported as an absence. Not once, anywhere in the file.
Peptide, longevity, regenerative and HRT practices where the person accountable for sourcing decisions is the person who signs for them.
Larger supplier estates, more molecules, more locations — and a greater need for one consistent evidence record across the organization.
I founded PeptEye and built its method — the four-layer register, the three-state discipline, and the 52-clinic register the specimen is drawn from.
I am neither a clinician nor a pharmacist. I build and advise companies, specializing in business diagnostics and information intelligence systems, turning scattered public record into something a decision-maker can act on. Peptide sourcing is that problem exactly: the evidence is already public, and assembling it is the part almost nobody does.
Every register is worked to that same documented method, against primary sources. No finding is ever taken from a supplier's own marketing material, and every line traces to a source you can open yourself. That is what makes a PeptEye file reliable — the method and the sources, not the judgment of any one person.
PeptEye is an independent supplier-evidence intelligence company focused on clinical peptide, GLP-1, HRT and longevity supply chains.
PeptEye accepts no referral fees, commissions, paid placement or promotional consideration from any entity it evaluates, and does not commercially serve both sides of the same supply relationship.We do not test product, and we do not provide medical or legal advice. Documentary verification establishes whether a document is genuine and whether a record exists. It establishes nothing about the material in the vial.
As a matter of public record, we record the published regulatory position for each compound. PeptEye does not draw legal conclusions from it; that is a question for your counsel, and the register is built so counsel can answer it.
Because the gap already exists. The register does not create it — it dates it, and it dates the day you started closing it. The file is yours: we do not publish it, we do not name you anywhere, and we do not sell findings to anyone. If privilege matters to you, commission the work through your attorney and the file lands with them. What you cannot do is un-know it once a board, a carrier or a plaintiff's lawyer asks the same question we did — and they will ask it cold, with no file in front of you.
Your pharmacy can attest to what your pharmacy did. It cannot evidence what is published about the substances you prescribe, whether the federal position on them has moved, or whether the documentation you hold would stand up if it were read by someone who was not already inclined to believe it. Across a 52-clinic register, not one clinic named its compounding pharmacy in public.
Not without your written instruction. The public-record layer is built entirely from sources anyone can reach. Supplier contact only happens if you ask for it and agree the wording first.
We confirm scope and fee before any work begins. Most engagements are delivered within five business days of scope confirmation. Larger estates and multi-site organizations are quoted with their own timeline up front — never open-ended.
It goes in the file, dated, with its source, and it goes to you — nowhere else. We draw no legal conclusion about it, because that is a question for your counsel, and the register is built so your counsel can answer it. You will not read about your own clinic in anything we publish.
No, and anyone selling you one for peptides is overselling. There is no certification to issue. What exists is a documented, dated, sourced record of what can and cannot be established — and an explicit list of what only your own files can close.
Tell us about your practice and the scope of the estate you want reviewed.
You do not need to provide supplier records to make an initial
inquiry.
Supplier Evidence Audit — from $2,500.
Real public-source reconstruction · clinic identity removed · not a commissioned client engagement